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In the original version of this Article the following
authors were omitted:
• Claudia Rossig (University Children’s Hospital of
Münster, Münster, Germany)
• Paul Schlegel (University Children’s Hospital of
Würzburg, Würzburg, Germany)
• Jean-Pierre Bourquin (University Children’s Hospital,
Switzerland)
• Aurelie Cabannes (University Hospital Saint-Louis,
Paris, France)
• Luciano Dalla-Pozza (Children’s Hospital at West-
mead, Sydney, Australia)
• Sarah Alexander (The Hospital for Sick Children,
Toronto, Canada)
• Michel Zwaan (Erasmus MC, University Medical
Center, Rotterdam, the Netherlands)
• Amrana Quereshi (Oxford University Hospitals, UK)
• Keith August (Children’s Mercy Hospital, Kansas City,
MO, USA)
All authors agree to the inclusion of these added authors
The acknowledgments section has also been updated to
read:
We thank the research coordinators and following phy-
sicians at pediatric cancer centers for contributing data to
this project: Prashant Hiwarkar and Jayashree Motwani,
Birmingham Women’s and Children’s Hospital, UK; Kelly
Maloney, Children’s Hospital of Colorado, USA; Mylene
Bassal, Children’s Hospital of Eastern Ontario, Canada;
Yoav Messinger and Joanna Perkins, Children’s Hospital
of Minnesota, USA; Van Huynh, Children’s Hospital of
Orange County, USA; Richard Ho, Children’s Hospital at
Vanderbilt, USA; Joanne Chuah and Jessa Morales,
* Deepa Bhojwani
dbhojwani@chla.usc.edu
1 Children’s Hospital Los Angeles and Keck School of Medicine,
University of Southern California, Los Angeles, CA, USA
2 National Cancer Institute, Bethesda, MD, USA
3 Mayo Clinic, Rochester, MN, USA
4 Cincinnati Children’s Hospital Medical Center, University of
Cincinnati School of Medicine, Cincinnati, OH, USA
5 University of Chicago Medicine Comer Children’s Hospital,
Chicago, IL, USA
6 Oxford University Hospitals, Oxford, UK
7 University Hospital Saint-Louis, Paris, France
8 University Children’s Hospital of Würzburg, Würzburg, Germany
9 University Children’s Hospital of Münster, Münster, Germany
10 Children’s Hospital at West-mead, Sydney, Australia
11 Children’s Mercy Hospital, Kansas City, MO, USA
12 The Hospital for Sick Children, Toronto, Canada
13 University Children’s Hospital, Zurich, Switzerland
14 Erasmus MC, University Medical Center, Rotterdam, the
Netherlands
15 New York University Langone Medical Center, New York, NY,
USA
16 Benioff Children’s Hospital and the Helen Diller Family
Comprehensive Cancer Center, University of California San
Francisco, San Francisco, CA, USA
17 Childrens Hospital of Philadelphia, University of Pennsylvania,
Philadelphia, PA, USA
Correction 1061
Children’s Hospital at Westmead, Australia; Donald Wells,
Dell Children’s Hospital, USA; Nicolas Boissel, Hospital
Saint-Louis, France; Tannie Huang, Kaiser Permanente,
USA; Stacey Marjerrison, McMaster Children’s Hospital,
Canada; William Carroll and Joanna Pierro, New York
University Langone Medical Center, USA; Ajay Vora,
Shefﬁeld Children’s Hospital, UK; Donna Lancaster, The
Royal Marsden Hospital, UK; Lucie Šrámková, University
Hospital Motol, Czech Republic; Chatchawin Assanasen,
University of Texas Health Science Center, San Antonio,
USA; Rupert Handgretinger, University of Tübingen,
Germany.
This has now been corrected in both the PDF and HTML
versions of the Article.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adaptation,
distribution and reproduction in any medium or format, as long as you
give appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made. The images or other third party material in this article are
included in the article’s Creative Commons license, unless indicated
otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will
need to obtain permission directly from the copyright holder. To view a
copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
1062 Correction
